Psychiatric research
Last year Professor W S Peart drew attention to the current paucity of research in psychiatry and discussed aetiology and possible treatment (Peart 1979) . He wondered whether psychiatrists were lacking in that brand of natural curiosity coupled with a reluctance to accept the authoritative view which make prime ingredients of the research outlook. He spoke of a quantitative and qualitative deficiency' in graduates entering the field. He cast a critical eye over the state of academic psychiatry in the medical schools. He intimated that the prescribed training programmes under the auspices of the Royal College of Psychiatrists might put a damper on the budding researcher. He concluded with a robust exhortation to those concerned to 'move optimistically and expeditiously'.
Certainly if one takes as an index money spent on psychiatric research by the Medical Research Council and the Department of Health and Social Security then there is no doubt that psychiatry lags behind other major medical disciplines. Officials claim, however, that this is not due to antipathy on the part of funding bodies but rather to a dearth of good quality applications. Accepting this assertion, is the cause to be found in a lack of bright, lively recruits with enquiring minds; the stultifying influence of current training or the intrinsic difficulty of the subject?
As a teacher I have found that many first-class medical students show a keen interest in psychiatry during their clerkship. A few years later I have seen them opt for general practice as a branch of medicine offering rapid advancement and providing plenty of scope for exercising an interest in social and psychological aspects. I very much hope that the possibility now afforded by new General Medical Council guidelines, of including psychiatry in the pre-registration menu, will be vigorously pursued. I believe the preregistration year to be very influential in determining final career choice.
Let us assume that a spark is kindled in the breast of an undergraduate or young doctor by contact with one of the overworked and (following the new consultant contract) possibly underpaid members of the tiny academic departments of psychiatry. What hope is there of fanning it into a steady flame? The right apprenticeship in reasonably sheltered surroundings is the answer and there are still ways of achieving this in certain University and Research Council settings. After a small number of years, however, the apprentice must decide whether to pursue the research life full-time, part-time or scarcely at all. Perhaps the alpha-plus man need never worry about his bread 0141-0768/80/110768-02/$01.00/0 and butter but it seems to me that the life of the average career medical research worker has, in recent years, lost some of its quality through an increasing emphasis on accountability by the funding bodies. Peart's suggestion of the establishment of additional posts in academic departments with the explicit aim of making more time available for research is most apposite. His membership of the Board of the Wellcome Trust gives an added dimension to this excellent idea.
As a former Dean of the Royal College of Psychiatrists and currently Chairman of the Joint Committee on Higher Psychiatric Training, I am naturally a trifle sensitive to the view that the educational policy of the College and of the Association of University Teachers of Psychiatry is inimical to the trainee with a research bent. The research option of the MRCPsych and the generous recognition of time spent in research both before Membership and during higher training are designed to stimulate and encourage original work rather than the reverse. In this connection research training in a cognate discipline, e.g. epidemiology, genetics, pharmacology, biochemistry, would be of great potential value and the College would be very favourably disposed to such arrangements. In this way the 'bridge man' mentioned by Professor Peart and regarded by him as of cardinal importance might be born.
What about the intrinsic difficulty of the subject? There are large and important areas of psychiatry, e.g. disordered personality, psychotherapy, where concepts are hard to pin down and where problems of measurement and of evaluation proliferate. Although it is tempting to seek the sixpence where the lamp burns brightest these shadier areas must be explored using tools which are necessarily imprecise and subjective. I believe that workers who enter these boggy pastures should be given wide latitude by funding bodies to pursue novel approaches. At this point I would like to enter a plea for a more constructive dialogue between funding bodies and applicants for support. Receipt of a laconic rejection slip is traumatic especially for the neophyte. I serve currently as Chairman of the Welsh Scheme for the Development of Health and Social Research (National Health Service locally organized research). We try to make the processing of applications a useful educational experience with feedback of comments (anonymously) from referees and with offers of help and advice from members of the committee.
In summary, then, I share Peart's view that psychiatric research is something of a delicate plant and has shown signs of wilting latterly. I also agree with some of his remedial measures,
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including an infusion of new posts to strengthen small departments and to give more scope for research activity. Also I applaud the crossfertilization between departments of psychiatry and a wide variety of basic science departments. Recruitment of good minds is of central importance and the College, together with the Association of University Teachers of Psychiatry and the Association of Psychiatrists in Training, is planning a special conference to examine all aspects of this thorny problem.
Young trainees, bewildered by the rich complexity of psychiatry and the absence of unequivocal landmarks will often, in their eagerness for a sign, latch onto some fairly narrow dogmatically propounded approach to mental disorders and suspend judgment. Senior colleagues bear a responsibility to nurture in their pupils the critical open mind with its penumbra of uncertainty and anxiety and, hopefully, to prepare the ground to bear a little research fruit. 
Inhalation therapy
The respiratory system is in a special though not unique position with respect to therapy, particularly when treating conditions associated with airways obstruction. A variety of drugs may be administered directly rather than by a more circuitous route, achieving a maximum effect with a very much smaller dosage when compared to oral administration of a similar drug. Unwanted side effects are kept to a minimum. As far as bronchodilatation is concerned other advantages include the rapid onset of action with peak effect which is reached far sooner than in the case of oral bronchodilators; a duration of action comparable with oral therapy; and in patients with intermittent rather than chronic airways obstruction, a reliable method of obtaining relief as and when 0141-0768/80/110769-02/$01.00/0 necessary, rather than continuous oral therapy some of which will be unnecessary. Despite the obvious advantage of inhaled therapy, oral bronchodilators retain their popularity throughout the spectrum of conditions associated with airways obstruction. Many clinicians, especially in general practice, and many patients, seem reluctant to use inhaled drugs of any sort. One can appreciate that their fears are related to the 'epidemic' of asthma deaths in the United Kingdom in the I960s, which it was origially suggested was due to excessive use of isoprenaline-containing aerosols. The evidence which has become available since then has not borne out this suggestion. A more plausible explanation is the development of resistance to beta-adrenoceptor stimulants, with diminution of effective endogenous sympathetic drive to the bronchi on which asthmatics rely to maintain effective bronchodilatation (Conolly et al. 1971) . Be that as it may, abuse of bronchodilator aerosols is undoubtedly a dangerous practice.
There are many factors which influence the therapeutic activity of a drug delivered by pressurized aerosol. The composition of the drug and propellant, the physical characteristics of the delivery system, and to some extent the magnitude and distribution of the patient's inspiratory airflow can be controlled. In connection with the last, how important is the development of a 'correct' technique in the use of pressurized aerosols? In this issue Newman et al. (page 000) offer a convincing demonstration in their patients under controlled conditions that a slow, deep inhalation of terbutaline sulphate with a tensecond breath-holding pause, irrespective of the lung volume at which the aerosol is inhaled, offers the best chance of maximal bronchodilatation. Their methods are reliable and their proposals are worthy of serious consideration. How applicable such laboratory investigations are to the clinical situation is, however, less certain. Many patients in urgent need of relief may be unable to follow either of the principal instructions. Further, any benefits to the patients from improved technique are likely to be as great, if not greater, from more efficient use of topical steroid treatment delivered by aerosol.
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